Grant Industries ~ Granactive AR-1423

ELMWOOD PARK, N.J.—Grant Industries Inc. launched Granactive AR-1423, a delivery matrix that can be used in cosmetic treatments to alleviate the redness associated with red (rosacea-like) skin types or after mild sun exposure. It combines a redness diminishing peptide, along with the antioxidant properties of tea, the calming properties of boswellia serrata and the soothing quality of honey. Granactive AR-1423 contains Tetrapeptide-14, a specific peptide sequence (designed by their supply partner Helix Biomedix). It acts by down regulating interleukin-6 (IL-6) to prevent inflammation, which in turn reduces MMP-1 damage with the net effect of a bright and even skin appearance.
Granactive AR-1423 was screened in a leave-on cosmetic treatment at a 5-percent level on several subjects having excessive redness on their face. This cosmetic treatment using the combination of Tetrapeptide-14 and botanicals was effective at diminishing the redness by 50 percent during the course of the four-week study.